ArticleCancer management and research2018

Health-related quality of life for gemcitabine and nab-paclitaxel plus radiotherapy versus gemcitabine and S-1 plus radiotherapy in patients with metastatic pancreatic cancer.

Xiaofei Zhu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.